This activity is supported by educational grants from AbbVie, Ariad Pharmaceuticals, Inc., Baxalta US Inc., Bristol-Myers Squibb, Celgene, Genentech, Inc., Gilead, Incyte Corporation, Infinity Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Pharmacyclics LLC and Janssen Biotech, Inc., Seattle Genetics, Takeda Oncology, and TG Therapeutics, Inc.
Friday, March 18, 2016
10:50 AM - 11:35 AM
Application of Artificial Intelligence and Robotics to Medicine
Corinna (Cori) E. Lathan, PhD
Board Chair and CEO
Silver Spring, MD
Dr. Corinna Lathan is the co-founder and CEO of AnthroTronix, a biomedical engineering research and development company and a leader in digital healthcare technology development focusing on brain and behavioral health, which has been featured at the Forbes Healthcare Summit Innovation Showcase and the 2015 Alzheimer's Association Conference.
Dr. Lathan was named a Technology Pioneer and a Young Global Leader by the World Economic Forum and currently serves as chair of their Global Agenda Council for Artificial Intelligence and Robotics. Her work has been featured in Forbes, Time, and The New Yorker magazines, as well as led to such distinctions as Maryland's "Top Innovator of the Year," MIT Technology Review magazine's "Top 100 World Innovators," and one of Fast Company magazine's "Most Creative People in Business." In an interview with NPR, Dr. Lathan discusses what she envisions for the future, and technology.
Dr. Lathan is actively involved in STEM educational outreach programs that empower women and minorities in science and technology. She is the founder of Keys to Empowering Youth for junior high school girls, a judge for the FIRST and VEX robotics programs, an advisor to the KID Museum Makerspace, and a board member of the National Black Child Development Institute. She is also on the board of Engineering World Health, which supports the emergence of healthcare technology in the developing world.
Prior to founding AnthroTronix, Dr. Lathan was an associate professor of biomedical engineering at The Catholic University of America and an adjunct associate professor of aerospace engineering at the University of Maryland, College Park. Dr. Lathan received her BA in biopsychology and mathematics from Swarthmore College and an MS in aeronautics and astronautics, as well as a PhD in neuroscience, from MIT.
Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors
Apr 28, 2018
April 28, 2018
New York, NY